Abstract
The importance of lowering blood pressure (BP) in hypertensive subjects is well known but the relationship between hypertension and cognitive function is controversial. This article reviews the role of hypertension in the aetiology of cognitive impairment and the relationships between BP, cerebral perfusion and cognition. It also summarizes findings of studies addressing the effect of antihypertensive therapy and cognition. An electronic database search of MEDLINE, EMBASE and the Cochrane Library and extensive manual searching of articles were conducted to identify studies that have used objective measurements of BP and neuropsychological tests to investigate the relationship among hypertension, cognitive function and/or antihypertensive treatment. In total, 28 cross-sectional studies, 22 longitudinal studies and 8 randomized placebo-controlled trials met the inclusion criteria. Cross-sectional studies showed mixed relationships between higher BP and cognition, with many studies showing no correlation or even J- or U-shaped associations. The majority of longitudinal studies demonstrated elevated BP to be associated with cognitive decline. Randomized studies demonstrated heterogeneous and, sometimes conflicting, effects of BP lowering on cognitive function. Suggested reasons for this heterogeneity include multiple mechanisms by which hypertension affects the brain, the variety of cognitive instruments used for assessment and differences in antihypertensive treatments. Although lowering the BP is beneficial in most patients with vascular risk factors, the effects of BP reduction on cognition remain unclear. Given the predicted upswing in people with cognitive impairments, the time is right for randomized clinical trials with specific cognitive end points to examine the relationship between cognitive function and hypertension and guide practice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reduction in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–838.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.
PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033–1041.
Dufouil C, Chalmers C, Coskun O, Besancon V, Bousser M-G, Guillon P et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke. The PROGRESS (Perindopril Protection against Recurrent Stroke Study) magnetic resonance imaging substudy. Circulation 2005; 112: 1644–1650.
Spence JD . Cerebral consequences of hypertension: where do they lead? J Hypertens Suppl 1996; 14: S139–S145.
Skoog I . A review on blood pressure and ischaemic white matter lesions. Dement Geriatr Cogn Disord 1998; 9 (Suppl 1): 13–19.
O’Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SC, Markus HS . Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004; 75: 441–447.
de la Torre JC, Fortin T . A chronic physiological rat model of Alzheimer's disease. Behav Brain Res 1994; 63: 35–40.
Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker III JC . Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995; 131: 162–169.
Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T . Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004; 226: 75–80.
O’Brien JT, Erkinjuntii E, Reisberg B, Roman G, Sawada T, Pantoni L et al. Vascular cognitive impairment. Lancet Neurol 2003; 2: 89–93.
Qiu C, Winblad B, Fratiglioni L . The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4: 487–499.
Cummings JL . Frontal–subcortical circuits and human behavior. J Psychosom Res 1998; 44: 627–628.
Birns J, Markus H, Kalra L . Blood pressure reduction for vascular risk: is there a price to be paid? Stroke 2005; 36: 1308–1313.
Shi J, Yang SH, Stubley L, Day AL, Simpkins JW . Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 2000; 853: 1–4.
Tanaka M, Fukuyama H, Yamauchi H, Narita M, Nabatame H, Yokode M et al. Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. J Neuroimag 2002; 12: 112–118.
Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ . Low blood pressure and the risk of dementia in very old individuals. Neurology 2003; 61: 1667–1672.
Wallace RB, Lemke JH, Morris MC, Goodenberger M, Kohout F, Hinrichs JV . Relationship of free-recall memory to hypertension in the elderly: the Iowa 65+ Rural Health Study. J Chronic Dis 1985; 38: 475–481.
Farmer ME, White LR, Abbott RD, Wolz MM, Wolf PA . Blood pressure and cognitive performance: the Framingham Study. Am J Epidemiol 1987; 126: 1103–1114.
Elias MF, Robbins MA, Schultz Jr NR, Pierce TW . Is blood pressure an important variable in research on aging and neuropsychological test performance? J Gerontol 1990; 45: P128–P135.
Scherr PA, Hebert LE, Smith IA, Evans DA . Relation of blood pressure to cognitive functions in the elderly. Am J Epidemiol 1991; 134: 1303–1315.
Starr JM, Whalley LJ, Inch S, Schering PA . Blood pressure and cognitive function in healthy old people. J Am Geriatr Soc 1993; 41: 753–756.
Desmond DW, Tatemichi TK, Paik M, Stern Y . Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993; 50: 162–166.
Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hänninen T et al. Essential hypertension and cognitive function: the role of hyperinsulinemia. Hypertension 1993; 22: 771–779.
Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ . The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274: 1846–1851.
Gale CR, Martyn CN, Cooper C . Cognitive impairment and mortality in a cohort of elderly people. Br Med J 1996; 312: 608–611.
Guo Z, Fratiglioni L, Winblad B, Viitanen M . Blood pressure and performance on the Mini-Mental State Examination in the very old: cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol 1997; 145: 1106–1113.
Cacciatore F, Abete P, Ferrera N, Paolisso G, Amato L, Canonico S et al. The role of blood pressure in cognitive impairment in an elderly population. J Hypertens 1997; 15: 135–142.
van Boxtel MPJ, Gaillard C, Houx PJ, Buntinx F, de Leeuw PW, Jolles J . Can the blood pressure predict task performance in a healthy population sample? J Hypertens 1997; 15: 1069–1076.
Cerhan JR, Folsom AR, Mortimer JA, Shahar E, Knopman DS, McGovern PG et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 1998; 44: 95–105.
Kilander L, Nyman H, Boberg M, Hansson L, Lithell H . Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998; 31: 780–786.
Seux M-L, Thijs L, Forette F, Staessen JA, Birkenhäger WH, Bulpitt CJ et al. Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project. J Hypertens 1998; 16: 963–969.
Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA . Current and remote blood pressure and cognitive decline. JAMA 1999; 281: 438–445.
Harrington F, Saxby BK, McKeith IG, Wesnes K, Ford GA . Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000; 36: 1079–1082.
Di Carlo A, Baldereschi M, Amaducci L, Maggi S, Grigoletto F, Scarlato G et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc 2000; 48: 775–782.
Stewart R, Richards M, Brayne C, Mann A . Vascular risk and cognitive impairment in an older, British, African-Caribbean population. J Am Geriatr Soc 2001; 49: 263–269.
André-Petersson L, Hagberg B, Janzon L, Steen G . A comparison of cognitive ability in normotensive and hypertensive 68-year-old men: results from population study ‘men born in 1914’, in Malmö, Sweden. Exp Aging Res 2001; 27: 319–340.
Izquierdo-Porrera AM, Waldstein SR . Cardiovascular risk factors and cognitive function in African Americans. J Gerontol B Psychol Sci Soc Sci 2002; 57: P377–P380.
Morris MC, Scherr PA, Hebert LE, Bennett DA, Wilson RS, Glynn RJ et al. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology 2002; 21: 123–130.
Budge MM, de Jager C, Hogervorst E, Smith AD, Oxford Project To Investigate Memory and Ageing (OPTIMA). Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc 2002; 50: 2014–2018.
Paran E, Anson O, Reuveni H . Blood pressure and cognitive functioning among independent elderly. Am J Hypertens 2003; 16: 818–826.
Pandav R, Dodge HH, DeKosky ST, Ganguli M . Blood pressure and cognitive impairment in India and the United States: a cross-national epidemiological study. Arch Neurol 2003; 60: 1123–1128.
Kähönen-Väre M, Brunni-Hakala S, Lindroos M, Pitkala K, Strandberg T, Tilvis R . Left ventricular hypertrophy and blood pressure as predictors of cognitive decline in old age. Aging Clin Exp Res 2004; 16: 147–152.
Kuo HK, Sorond F, Iloputaife I, Gagnon M, Milberg W, Lipsitz LA . Effect of blood pressure on cognitive functions in elderly persons. J Gerontol A Biol Sci Med Sci 2004; 59: 1191–1194.
Waldstein SR, Giggey PP, Thayer JF, Zonderman AB . Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension 2005; 45: 374–379.
Wilkie F, Eisdorfer C . Intelligence and blood pressure in the aged. Science 1971; 172: 959–962.
Elias MF, Wolf PA, D’Agostino RB, Cobb J, White LR . Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993; 138: 353–364.
Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 1998; 51: 986–993.
Swan GE, Carmelli D, Larue A . Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke 1998; 29: 2334–2340.
Sacktor N, Gray S, Kawas C, Herbst J, Costa P, Fleg J . Systolic blood pressure within an intermediate range may reduce memory loss in an elderly hypertensive cohort. J Geriatr Psychiatry Neurol 1999; 12: 1–6.
Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L . The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999; 282: 40–46.
Tzourio C, Dufouil C, Ducimetière P, Alpérovitch A . Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology 1999; 53: 1948–1952.
Kilander L, Nyman H, Boberg M, Lithell H . The association between low diastolic blood pressure in middle age and cognitive function in old age. A population-based study. Age Ageing 2000; 29: 243–248.
Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42–48.
Reinprecht F, Elmståhl S, Janzon L, André-Petersson L . Hypertension and changes of cognitive function in 81-year-old men: a 13-year follow-up of the population study ‘men born in 1914’, Sweden. J Hypertens 2003; 21: 57–66.
Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB . Lower cognitive function in the presence of obesity and hypertension: the Framingham Heart Study. Int J Obes Relat Metab Disord 2003; 27: 260–268.
Piguet O, Grayson DA, Creasey H, Bennett HP, Brooks WS, Waite LM et al. Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study. Neuroepidemiology 2003; 22: 165–171.
Elias PK, Elias MF, Robbins MA, Budge MM . Blood pressure-related cognitive decline: does age make a difference? Hypertension 2004; 44: 631–636.
Okumiya K, Matsubayashi K, Wada T, Osaki Y, Doi Y, Ozawa T . J-curve relation between blood pressure and decline in cognitive function in older people living in community, Japan. J Am Geriatr Soc 1997; 45: 1032–1033.
Bohannon AD, Fillenbaum GG, Pieper CF, Hanlon JT, Blazer DG . Relationship of race/ethnicity and blood pressure to change in cognitive function. J Am Geriatr Soc 2002; 50: 424–429.
Hebert LE, Scherr PA, Bennett DA, Bienias JL, Wilson RS, Morris MC et al. Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology 2004; 62: 2021–2024.
Gorelick PB . Risk factors for vascular dementia and Alzheimer disease. Stroke 2004; 35 (11 Suppl 1): 2620–2622.
Birns J, Morris R, Jarosz J, Markus H, Kalra L . Ethnic differences in the cerebrovascular impact of hypertension. Cerebrovasc Dis 2008; 25: 408–416.
Luchsinger JA, Tang MX, Shea S, Mayeux R . Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004; 63: 1187–1192.
Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476–483.
Birns J, Morris R, Donaldson N, Kalra L . The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials. J Hypertens 2006; 24: 1907–1914.
Lasser NL, Nash J, Lasser VI, Hamill SJ, Batey DM . Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide. Am J Med 1989; 86: 98–103.
McCorvey Jr E, Wright Jr JT, Culbert JP, McKenney JM, Proctor JD, Annett MP . Effect of hydrochlorothiazide, enalapril, and propranolol on quality of life and cognitive and motor function in hypertensive patients. Clin Pharm 1993; 12: 300–305.
Applegate WB, Pressels S, Wittes J, Luhr J, Shekelle RB, Camel GH et al. Impact of the treatment of isolated systolic hypertension on behavioural variables: results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 1994; 154: 2154–2160.
Prince M, Bird AS, Blizard RA, Mann AH . Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. Br Med J 1996; 312: 801–805.
Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 2046–2052.
Denolle T, Sassano P, Allain H, Bentue-Ferrer D, Breton S, Cimarosti I et al. Effects of nicardipine and clonidine on cognitive functions and electroencephalography in hypertensive patients. Fundam Clin Pharmacol 2002; 16: 527–535.
Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Inter Med 2003; 163: 1069–1075.
Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875–886.
Dimsdale JE, Newton RP, Joist T . Neuropsychological side-effects of beta blockers. Arch Intern Med 1989; 149: 514–525.
Twamley EW, Ropacki SA, Bondi MW . Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2006; 12: 707–735.
Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC . Subcortical ischaemic vascular dementia. Lancet Neurol 2002; 1: 426–436.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure
The authors report no conflict of interest.
Rights and permissions
About this article
Cite this article
Birns, J., Kalra, L. Cognitive function and hypertension. J Hum Hypertens 23, 86–96 (2009). https://doi.org/10.1038/jhh.2008.80
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2008.80
Keywords
This article is cited by
-
Is cognitive status of the Cretan elderly aged ≥ 75 years associated with known behavioral and vascular risk factors?
Journal of Public Health (2020)
-
Associations of central and brachial blood pressure with cognitive function: a population-based study
Journal of Human Hypertension (2016)
-
The association between the prevalence, treatment and control of hypertension and the risk of mild cognitive impairment in an elderly urban population in China
Hypertension Research (2016)
-
Clinical study on acupoint massage in improving cognitive function and sleep quality of elderly patients with hypertension
Journal of Acupuncture and Tuina Science (2015)